FdaApplication
ANDA 203560
Identifiers
- fda_app_no: ANDA203560
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS ELIZABETH LLC |
| application_type | ANDA |
| approval_date | 2016-01-26 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL |
| DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL |
| DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL |
3 products